Here, BC-PDMs were characterized by enhanced levels of beta-catenin, FoxO3a, Akt-pSer473, CREB, CREB-pSer133, PDK1 and IKKalpha-pThr23. The gene discussed is FOXO3; the disease is breast cancer.